Engineers Gate Manager LP Alnylam Pharmaceuticals, Inc. Transaction History

Engineers Gate Manager LP

$3.68 Billion
Q1 2024

A detailed history of Engineers Gate Manager LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 24,723 shares of ALNY stock, worth $6.12 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

24,723

Previous 17,431 41.83%

Holding current value

$6.12 Million

Previous $3.34 Million 10.73%

% of portfolio

0.1%

Previous 0.1%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $1.07 Million - $1.45 Million	7,292 Added 41.83%	24,723 $3.69 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $2.64 Million - $3.43 Million	17,431 New	17,431 $3.34 Million
Q2 2023 Aug 14, 2023	SELL	$185.01 - $212.05 $168,174 - $192,753	-909 Reduced 14.67%	5,286 $1 Million
Q1 2023 May 15, 2023	BUY	$182.66 - $235.53 $1.13 Million - $1.46 Million	6,195 New	6,195 $1.24 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $480,318 - $804,344	-3,467 Reduced 63.92%	1,957 $392,000

Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $653,158 - $918,228	5,424 New	5,424 $791,000
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $253,088 - $346,080	-1,990 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $136,583 - $179,152	856 Added 75.49%	1,990 $337,000
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $2.52 Million - $3.08 Million	-14,830 Reduced 92.9%	1,134 $214,000
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $1.68 Million - $2.31 Million	13,054 Added 448.59%	15,964 $2.71 Million
Q1 2021 May 17, 2021	BUY	$126.83 - $175.69 $53,268 - $73,789	420 Added 16.87%	2,910 $411,000
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $134,037 - $160,230	1,090 Added 77.86%	2,490 $324,000
Q3 2020 Nov 16, 2020	SELL	$121.19 - $165.49 $254,499 - $347,529	-2,100 Reduced 60.0%	1,400 $204,000
Q2 2020 Aug 17, 2020	BUY	$104.21 - $156.44 $364,735 - $547,540	3,500 New	3,500 $518,000
Q1 2020 May 15, 2020	SELL	$93.12 - $133.99 $303,571 - $436,807	-3,260 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $242,902 - $404,989	3,260 New	3,260 $375,000

Others Institutions Holding ALNY

# of Institutions

585

Shares Held

104M

Call Options Held

2.82M

Put Options Held

1.75M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.5B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Alnylam Pharmaceuticals, Inc. Transaction History